Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon Sep 09, 2017 11:54am
183 Views
Post# 26675529

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NewsAlthough you may think of me as a short or trader I am just a TST 
conscript that believes PL misled the market last year, which allowed PLI
to buy our equity cheap. If the burn and the delays were in the stock last fall 
I would own more shares at say 2 rather than 3. and be a lot less angry that PL told
the market a fairy tale. Yes the FDA yes will be a game changer but ask your 
local GP what his thoughts are on off label use with potential litigation risk.
Yes the specialist providing it for prescribed use are your best bet on immediate off label use
and after some proven off label success by them more doctors will use it. My view is that your
attempting to turn around an ocean liner not a 14 foot fishing boat and the break even day
is further out than most think. If PL under promised and over delivered that is a different scenario.
But I believe that he presents a much prettier picture than the facts support.
My go to on that was his "we raised 63 million" where in reality there was a fee paid and a
debt converted to shares for a cash in the bank net of about 50 million. I consider that weasel behaviour and the market no longer trusts him. And when someone talks of coming to my house tobeat me with their fists the urge to reply to every anti post is pretty much 100 %
Major FDA news requires a trading halt or PL's job so I don't expect any release on Monday.
Love to be wrong but my guess is still October. HT
Bullboard Posts